Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -27,149 | -31,707 | -41,862 | N/A |
| Depreciation Amortization | 4,068 | 4,432 | 3,831 | N/A |
| Accounts receivable | 264 | 1,130 | -1,562 | N/A |
| Accounts payable and accrued liabilities | -1,118 | -4,438 | 4,807 | N/A |
| Other Working Capital | -2,017 | 4,206 | 8,174 | N/A |
| Other Operating Activity | 1,072 | 5,539 | -2,577 | 0 |
| Operating Cash Flow | $-24,880 | $-20,838 | $-29,189 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -6,769 | -5,509 | -5,838 | N/A |
| Investing Cash Flow | $-6,769 | $-5,509 | $-5,838 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 63,750 | 21,250 | N/A | N/A |
| Debt Repayment | -11,250 | N/A | N/A | N/A |
| Common Stock Issued | 2 | 3 | 173 | N/A |
| Common Stock Repurchased | -2 | 0 | N/A | N/A |
| Other Financing Activity | -1,795 | -215 | 40,000 | 0 |
| Financing Cash Flow | $50,705 | $21,038 | $40,173 | $N/A |
| Beginning Cash Position | 7,077 | 12,386 | 7,240 | N/A |
| End Cash Position | 26,133 | 7,077 | 12,386 | N/A |
| Net Cash Flow | $19,056 | $-5,309 | $5,146 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -24,880 | -20,838 | -29,189 | N/A |
| Capital Expenditure | -6,770 | -5,509 | -5,840 | N/A |
| Free Cash Flow | -31,650 | -26,347 | -35,029 | 0 |